Evidence map›Paper›PMID 38712186›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Day 3 parasitemia and

Martin Kamilo Angwe, Norah Mwebaza, Sam Lubwama Nsobya, Patrick Vudriko, Savior Dralabu, Denis Omali, Maria Agnes Tumwebaze, Moses Ocan

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Martin Kamilo AngweDepartment of Pharmacology and Therapeutics, College of Health Science, Makerere University.ORCID 0000-0002-1211-7762
Norah MwebazaDepartment of Pharmacology and Therapeutics, College of Health Science, Makerere University.
Sam Lubwama NsobyaInfectious Diseases Research Collaboration, Makerere University.
Patrick VudrikoResearch Center for Tropical Diseases and Vector Control, Department of Pharmacy, Clinical and Comparative Medicine, School of Veterinary Medicine and Animal Resources, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University.
Savior DralabuResearch Center for Tropical Diseases and Vector Control, Department of Pharmacy, Clinical and Comparative Medicine, School of Veterinary Medicine and Animal Resources, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University.
Denis OmaliDepartment of Pharmacology and Therapeutics, College of Health Science, Makerere University.
Maria Agnes TumwebazeResearch Center for Tropical Diseases and Vector Control, Department of Pharmacy, Clinical and Comparative Medicine, School of Veterinary Medicine and Animal Resources, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University.
Moses OcanDepartment of Pharmacology and Therapeutics, College of Health Science, Makerere University.ORCID 0000-0002-8852-820X

Funding

Health Professions Education and training for strengthening the health system and services in UgandaR25TW011213 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI KIGULI, SARAH · 2018 to 2022
$3.4M
FIC NIH HHS R25 TW011213
6 · The paper itself

Abstract

Artemisinin resistance threatens malaria control and elimination efforts globally. Recent studies have reported the emergence of

Indexed as

Artemether-lumefantrineArtemisinin resistanceDay 3 parasitaemiaK13 mutationPlasmodium falciparum

Identifiers

PMID38712186
PMCPMC11071562

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.